ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Corporate Counsel at Cogent Biosciences - ApplyBlast

Corporate Counsel

Cogent Biosciences

1 month ago

3.8 on Glassdoor

Waltham, Massachusetts, United States

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Corporate Counsel will join a growing legal department to support transactional matters, including drafting, reviewing, and negotiating a portfolio of agreements for strategic transactions, research collaborations, and services arrangements. This role involves advising internal clients on business development projects, ensuring compliance with applicable laws, and mitigating legal risk to enable business growth in a fast-paced biotechnology environment. The position requires close collaboration with cross-functional teams to support the company's transition into a commercial-stage biotech company.

Responsibilities

Draft, review, and negotiate complex legal agreements and contracts
Provide strategic legal advice to cross-functional business teams
Monitor regulatory changes and ensure compliance with applicable laws

Skills

Qualifications

Juris Doctor (J.D.)

About Cogent Biosciences

cogentbio.com

Headquarters

Waltham, Massachusetts, United States

Company Size

51-200 employees

Founded

2014

View Profile

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases, including cancers, autoimmune conditions, and rare diseases. The company leverages validated biology to design best-in-class small molecule therapeutics, with its lead program bezuclastinib targeting conditions such as Systemic Mastocytosis and Gastrointestinal Stromal Tumors (GIST). Cogent operates discovery and development offices in Boulder, Colorado and Waltham, Massachusetts, and is actively advancing clinical-stage programs including a Phase 3 trial and an FDA-accepted NDA for bezuclastinib.